Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118336003 | 11833600 | 3 | F | 20160809 | 20151214 | 20160819 | EXP | US-TEVA-617517USA | TEVA | GOLOMB BA, KOSLIK HJ, REDD AJ. FLUOROQUINOLONE-INDUCED SERIOUS, PERSISTENT, MULTISYMPTOM ADVERSE EFFECTS. BMJ-CASE-REP 2015; :. | 23.00 | YR | F | Y | 0.00000 | 20160819 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118336003 | 11833600 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | 500MG 2 TIMES A DAY FOR 10 DAYS | N | 74124 | |||||||||
| 118336003 | 11833600 | 2 | SS | MOXIFLOXACIN. | MOXIFLOXACIN | 1 | Unknown | 400MG DAILY FOR 3 DAYS | N | 77437 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118336003 | 11833600 | 1 | Diarrhoea infectious |
| 118336003 | 11833600 | 2 | Oropharyngeal pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118336003 | 11833600 | DS |
| 118336003 | 11833600 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118336003 | 11833600 | Alopecia | |
| 118336003 | 11833600 | Amnesia | |
| 118336003 | 11833600 | Arthralgia | |
| 118336003 | 11833600 | Cognitive disorder | |
| 118336003 | 11833600 | Disturbance in attention | |
| 118336003 | 11833600 | Dizziness | |
| 118336003 | 11833600 | Dry eye | |
| 118336003 | 11833600 | Dry mouth | |
| 118336003 | 11833600 | Dyspnoea | |
| 118336003 | 11833600 | Fatigue | |
| 118336003 | 11833600 | Gastrointestinal pain | |
| 118336003 | 11833600 | Gastrooesophageal reflux disease | |
| 118336003 | 11833600 | Impaired gastric emptying | |
| 118336003 | 11833600 | Insomnia | |
| 118336003 | 11833600 | Irritable bowel syndrome | |
| 118336003 | 11833600 | Micturition urgency | |
| 118336003 | 11833600 | Migraine | |
| 118336003 | 11833600 | Mood swings | |
| 118336003 | 11833600 | Multiple chemical sensitivity | |
| 118336003 | 11833600 | Muscle contractions involuntary | |
| 118336003 | 11833600 | Muscular weakness | |
| 118336003 | 11833600 | Myalgia | |
| 118336003 | 11833600 | Mydriasis | |
| 118336003 | 11833600 | Nausea | |
| 118336003 | 11833600 | Orthostatic hypotension | |
| 118336003 | 11833600 | Polyneuropathy | |
| 118336003 | 11833600 | Postural orthostatic tachycardia syndrome | |
| 118336003 | 11833600 | Seizure | |
| 118336003 | 11833600 | Sinus disorder | |
| 118336003 | 11833600 | Sinusitis | |
| 118336003 | 11833600 | Tachycardia | |
| 118336003 | 11833600 | Tendonitis | |
| 118336003 | 11833600 | Toxicity to various agents | |
| 118336003 | 11833600 | Ulcerative keratitis | |
| 118336003 | 11833600 | Upper respiratory tract infection | |
| 118336003 | 11833600 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |